setpoint_facebook.jpg
SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs
November 03, 2021 09:00 ET | SetPoint Medical
VALENCIA, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapies for chronic autoimmune diseases, today announced the...
setpoint_facebook.jpg
SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows
March 03, 2021 09:00 ET | SetPoint Medical
VALENCIA, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that the...
setpoint_facebook.jpg
SetPoint Medical Announces First Patient Enrolled in the RESET-RA Study
February 01, 2021 09:00 ET | SetPoint Medical
VALENCIA, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced the enrollment...
setpoint_facebook.jpg
SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform
January 27, 2021 09:00 ET | SetPoint Medical
VALENCIA, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with...
setpoint_facebook.jpg
The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis
July 29, 2020 09:00 ET | SetPoint Medical
VALENCIA, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- SetPoint Medical, Inc. today announced that data from a first-in-human pilot trial that evaluated its proprietary Vagus Nerve Stimulation (VNS)...
setpoint_facebook.jpg
SetPoint Medical Receives IDE Approval for U.S. Pivotal Trial to Study its Bioelectronic Platform in Rheumatoid Arthritis Patients
May 06, 2020 09:00 ET | SetPoint Medical
VALENCIA, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that it has...
setpoint_facebook.jpg
SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019
October 29, 2019 09:00 ET | SetPoint Medical
VALENCIA, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results...
setpoint_facebook.jpg
SetPoint Medical Appoints Anna Gawlicka as VP of Clinical Affairs
September 10, 2019 09:00 ET | SetPoint Medical
VALENCIA, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage company developing therapy for chronic autoimmune diseases, today announced the appointment of Anna Gawlicka,...
setpoint_facebook.jpg
SetPoint Medical to Present Results From The U.S. Pilot Study in Rheumatoid Arthritis Patients at European Congress of Rheumatology (EULAR) 2019
June 03, 2019 13:26 ET | SetPoint Medical
VALENCIA, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results...
setpoint_facebook.jpg
SetPoint Medical Reports New Data Demonstrating its Bioelectronic Medicine Effectively Reduces Crohn’s Disease Activity
May 20, 2019 09:00 ET | SetPoint Medical
VALENCIA, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced new positive...